152 related articles for article (PubMed ID: 38326746)
61. Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Quantification of Liver Fat Using a New Quantitative Ultrasound Technique.
Lin SC; Heba E; Wolfson T; Ang B; Gamst A; Han A; Erdman JW; O'Brien WD; Andre MP; Sirlin CB; Loomba R
Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1337-1345.e6. PubMed ID: 25478922
[TBL] [Abstract][Full Text] [Related]
62. Hepatic tumors: region-of-interest versus volumetric analysis for quantification of attenuation at CT.
Chalian H; Tochetto SM; Töre HG; Rezai P; Yaghmai V
Radiology; 2012 Mar; 262(3):853-61. PubMed ID: 22357887
[TBL] [Abstract][Full Text] [Related]
63. Effect of hepatic steatosis on native T1 mapping of 3T magnetic resonance imaging in the assessment of T1 values for patients with non-alcoholic fatty liver disease.
Ahn JH; Yu JS; Park KS; Kang SH; Huh JH; Chang JS; Lee JH; Kim MY; Nickel MD; Kannengiesser S; Kim JY; Koh SB
Magn Reson Imaging; 2021 Jul; 80():1-8. PubMed ID: 33798658
[TBL] [Abstract][Full Text] [Related]
64. Multi-detector row helical CT of the liver: quantitative assessment of iodine concentration of intravenous contrast material on multiphasic CT--a prospective randomized study.
Tsurusaki M; Sugimoto K; Fujii M; Sugimura K
Radiat Med; 2004; 22(4):239-45. PubMed ID: 15468944
[TBL] [Abstract][Full Text] [Related]
65. Quantitative Liver MRI-Biopsy Correlation in Pediatric and Young Adult Patients With Nonalcoholic Fatty Liver Disease: Can One Be Used to Predict the Other?
Dillman JR; Trout AT; Costello EN; Serai SD; Bramlage KS; Kohli R; Xanthakos SA
AJR Am J Roentgenol; 2018 Jan; 210(1):166-174. PubMed ID: 29045180
[TBL] [Abstract][Full Text] [Related]
66. Virtual non-contrast for evaluation of liver parenchyma and vessels: results from 25 patients using multi-phase spectral-detector CT.
Laukamp KR; Ho V; Obmann VC; Herrmann K; Gupta A; Borggrefe J; Lennartz S; Große Hokamp N; Ramaiya N
Acta Radiol; 2020 Aug; 61(8):1143-1152. PubMed ID: 31856581
[TBL] [Abstract][Full Text] [Related]
67. Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease.
Hanniman E; Costa AF; Bowen CV; Abdolell M; Stueck A; McLeod M; Peltekian K; Rioux J; Clarke SE
J Magn Reson Imaging; 2022 Nov; 56(5):1448-1456. PubMed ID: 35285996
[TBL] [Abstract][Full Text] [Related]
68. Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility.
Kato S; Iwasaki A; Kurita Y; Arimoto J; Yamamoto T; Hasegawa S; Sato T; Imajo K; Hosono K; Kobayashi N; Yoneda M; Higurashi T; Kubota K; Utsunomiya D; Nakajima A
PLoS One; 2019; 14(12):e0224921. PubMed ID: 31790429
[TBL] [Abstract][Full Text] [Related]
69. Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
Awai K; Inoue M; Yagyu Y; Watanabe M; Sano T; Nin S; Koike R; Nishimura Y; Yamashita Y
Radiology; 2004 Dec; 233(3):682-8. PubMed ID: 15486215
[TBL] [Abstract][Full Text] [Related]
70. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.
Troelstra MA; Witjes JJ; van Dijk AM; Mak AL; Gurney-Champion O; Runge JH; Zwirs D; Stols-Gonçalves D; Zwinderman AH; Ten Wolde M; Monajemi H; Ramsoekh S; Sinkus R; van Delden OM; Beuers UH; Verheij J; Nieuwdorp M; Nederveen AJ; Holleboom AG
J Magn Reson Imaging; 2021 Dec; 54(6):1937-1949. PubMed ID: 33991378
[TBL] [Abstract][Full Text] [Related]
71. Repeatability and accuracy of various region-of-interest sampling strategies for hepatic MRI proton density fat fraction quantification.
Hong CW; Cui JY; Batakis D; Xu Y; Wolfson T; Gamst AC; Schlein AN; Negrete LM; Middleton MS; Hamilton G; Loomba R; Schwimmer JB; Fowler KJ; Sirlin CB
Abdom Radiol (NY); 2021 Jul; 46(7):3105-3116. PubMed ID: 33609166
[TBL] [Abstract][Full Text] [Related]
72. Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis.
Hooker JC; Hamilton G; Park CC; Liao S; Wolfson T; Dehkordy SF; Hong CW; Mamidipalli A; Gamst A; Loomba R; Sirlin CB
Abdom Radiol (NY); 2019 Feb; 44(2):482-492. PubMed ID: 30128694
[TBL] [Abstract][Full Text] [Related]
73. Material density hepatic steatosis quantification on intravenous contrast-enhanced rapid kilovolt (peak)-switching single-source dual-energy computed tomography.
Patel BN; Kumbla RA; Berland LL; Fineberg NS; Morgan DE
J Comput Assist Tomogr; 2013; 37(6):904-10. PubMed ID: 24270112
[TBL] [Abstract][Full Text] [Related]
74. Accuracy of PDFF estimation by magnitude-based and complex-based MRI in children with MR spectroscopy as a reference.
Haufe WM; Wolfson T; Hooker CA; Hooker JC; Covarrubias Y; Schlein AN; Hamilton G; Middleton MS; Angeles JE; Hernando D; Reeder SB; Schwimmer JB; Sirlin CB
J Magn Reson Imaging; 2017 Dec; 46(6):1641-1647. PubMed ID: 28323377
[TBL] [Abstract][Full Text] [Related]
75. Radiomics Analysis of Magnetic Resonance Proton Density Fat Fraction for the Diagnosis of Hepatic Steatosis in Patients With Suspected Non-Alcoholic Fatty Liver Disease.
Sim KC; Kim MJ; Cho Y; Kim HJ; Park BJ; Sung DJ; Han NY; Han YE; Kim TH; Lee YJ
J Korean Med Sci; 2022 Dec; 37(49):e339. PubMed ID: 36536543
[TBL] [Abstract][Full Text] [Related]
76. [Value of quantitative iodine-based material decomposition images with gemstone spectral CT imaging in the follow-up of patients with hepatocellular carcinoma after TACE treatment].
Xing G; Wang S; Li C; Zhao X; Zhou C
Zhonghua Zhong Liu Za Zhi; 2015 Mar; 37(3):208-12. PubMed ID: 25975791
[TBL] [Abstract][Full Text] [Related]
77. Noninvasive monitoring of hepatic steatosis: controlled attenuation parameter and magnetic resonance imaging-proton density fat fraction in patients with nonalcoholic fatty liver disease.
Lee SJ; Kim SU
Expert Rev Gastroenterol Hepatol; 2019 Jun; 13(6):523-530. PubMed ID: 31018719
[TBL] [Abstract][Full Text] [Related]
78. Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard.
Mu R; Xia YC; Zhu KY; Lu JY; Luo Q; Zhang L; Lin RK; Cai XB; Qu Y; Lu LG
J Dig Dis; 2023 Dec; 24(12):691-701. PubMed ID: 37994615
[TBL] [Abstract][Full Text] [Related]
79. The evaluation of haemodynamics in cirrhotic patients with spectral CT.
Zhao LQ; He W; Yan B; Wang HY; Wang J
Br J Radiol; 2013 Aug; 86(1028):20130228. PubMed ID: 23881800
[TBL] [Abstract][Full Text] [Related]
80. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.
Park CC; Nguyen P; Hernandez C; Bettencourt R; Ramirez K; Fortney L; Hooker J; Sy E; Savides MT; Alquiraish MH; Valasek MA; Rizo E; Richards L; Brenner D; Sirlin CB; Loomba R
Gastroenterology; 2017 Feb; 152(3):598-607.e2. PubMed ID: 27911262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
